(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Heparin is given prophylactically to patients to prevent these
DVT and PE
prototype thrombolytic drug
alteplase
antidote for warfarin
Vitamin K
laboratory test used to see if heparin is within therapeutic range
aPTT
The only oral direct thrombin inhibitor
dabigatran
Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
tranexamic acid
Antidote for heparin
Protamine Sulfate
Laboratory tests used to manage therapeutic range of warfarin
PTT and INR
An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
Plasminogen
Dissolution of blood clots
Thrombolysis
Prototype vitamin K antagonist
warfarin
A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
Heparin induced thrombocytopenia (HIT)
Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
Aminocaproic acid
Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
Disseminated intravascular coagulation (DIC)
Process that maintains the integrity of the vascular compartment.
Homeostasis
major side effect of Heparin therapy
Hemorrhage
Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
PCC
agents that dissolve blood clots
Thrombolytic Drugs
Acts in the liver to prevent synthesis of vitamin K
Action of warfarin
QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
3
Antidote for dabigatran
Idarucizumab
inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
Heparin
prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
Clopidogrel
direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
Rivaroxaban
